Psyence Biomedical Ltd. (PBM)
5.00
-0.16
(-3.10%)
USD |
NASDAQ |
Oct 05, 16:00
4.98
-0.02
(-0.40%)
After-Hours: 20:00
Psyence Biomedical EPS Diluted (Quarterly) : -3.178 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -3.178 |
| September 30, 2024 | 0.0426 |
| September 30, 2023 | -6.314 |
| June 30, 2023 | -0.0078 |
| March 31, 2023 | -0.0021 |
| December 31, 2022 | 0.0689 |
| September 30, 2022 | 0.0269 |
| Date | Value |
|---|---|
| June 30, 2022 | 5.374 |
| March 31, 2022 | 7.760 |
| December 31, 2021 | 19.07 |
| September 30, 2021 | -0.1035 |
| June 30, 2021 | -0.063 |
| March 31, 2021 | -0.0158 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -1.112 |
| Aurinia Pharmaceuticals, Inc. | 0.2802 |
| enGene Therapeutics, Inc. | -0.4661 |
| Medicus Pharma Ltd. | -0.1524 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.7533M |
| Total Expenses (Quarterly) | 0.7533M |